
OTCE 2020-2021 Subscription
This subscription includes two OTCE issues from 2020-2021 with CPEU.
Member Price $160.00
Nonmember Price $160.00
DPG/MIG Price $0.00
0 item(s) Subtotal $0,00
This subscription includes two OTCE issues from 2020-2021 with CPEU.
Member Price $160.00
Nonmember Price $160.00
DPG/MIG Price $0.00
This product is free for Diabetes DPG members.
As new OTCE issues are released throughout the year, you must visit the link sent in the confirmation email to access new issues. You will NOT receive an email notification upon release of new issues.
This subscription currently includes the following released OTCE issues:
On the Cutting Edge: Double Teamed: Collaborative Approaches for Mitigating CVD Risk in T2D (Vol. 40, No. 6)
In case you are not a basketball aficionado, the title "Double Teamed" refers to the defensive strategy frequently used against the opponent's best player. Coaches often assign two players to guard the highest scorer on the other team in order to limit the damage they can do. This title emphasizes the serious threat of cardiovascular disease (CVD) for those who live with type 2 diabetes (T2D) and to encourage all healthcare professionals to team up against this major adversary.
CPEU: 4.0
CPE Level: 2
The comprehensive approach to the management of type 2 diabetes and atherosclerotic cardiovascular disease (ASCVD) begins with understanding and stratifying risk. Dr. Baecher's article, Diabetes and Cardiovascular Risk – Understanding the Latest Assessment Strategies, outlines novel markers, risk enhancers and imaging tools to aid in making treatment decisions, especially in patients who are low/moderate risk or those with subclinical atherosclerosis.
The article Understanding Current Cardiovascular Treatment Guidelines for Adults with Diabetes will compare and contrast current guidelines to help RDNs and diabetes educators translate these recommendations into practice for the prevention and treatment of ASCVD in patients with diabetes.
The article Benefits of SGLT2 Inhibitors and GLP-1 Receptor Agonists: Beyond Glycemic Control will review the relationship between diabetes, CVD, and chronic kidney disease (CKD). Dr. Morgan Jones and Dr. Evan Sisson will discuss the important benefits of diabetes medications and offer practical advice for the RDNs supporting people with diabetes.
In the article Eating Patterns and Management of Cardiovascular Risk in Diabetes – Emerging Science, Karen Lau, MS, RDN, CDCES, explores the various eating patterns detailed in the 2019 Nutrition Consensus report. Through the lens of CVD risk reduction, plant-based, DASH and Mediterranean diets offer superior long term benefits.
It has been suggested that sleep and exercise should be considered "vital signs" that are assessed at each visit with our clients. Both of these articles, Insufficient Sleep as a Contributor to Cardiovascular Disease and Type 2 Diabetes Risk and Exercise as Medicine™ for Clients with Diabetes: Strategies for Increasing Movement, provide the background science linking sleep and inactivity to CVD as well as actionable tips for encouraging behavior changes that can help reduce risk.
In Expanded Roles for Registered Dietitian Nutritionists (RDNs) in Managing Diabetes and Cardiovascular Risk, the authors will explore how an RDN can expand their scope of practice in their institution and offer a road map for RDNs who are interested in expanding their own practice.
On the Cutting Edge: The Spectrum Of Hypoglycemia From Fear to Confidence (Vol. 41, No. 2)
This issue will present additional considerations to the basic 15:15 rule for the treatment of hypoglycemia in special populations and to accommodate advances in technology.
CPEU: 4.0
CPE Level: 2
The first article, Understanding, Assessing and Treating Fear of Hypoglycemia in Youth With Type 1 Diabetes and Their Parents, highlights the human elements of the hypoglycemia experience. For young persons with diabetes and their parents the fear of hypoglycemia (FOH) can significantly impact how diabetes is managed and the level of stress associated with the diagnosis of type 1 diabetes (T1D). This article, written by Clary and her team, offers a tool to identify FOH and describes programs to connect these individuals with additional support.
McElwee Malloy and Singh explore advances in insulin pumps and continuous glucose monitors (CGMs) in their article Diabetes Technology: Importance of Evaluating Both the Clinical and Psychosocial Impact of Hypoglycemia in People With Diabetes. They highlight the essential role of the registered dietitian nutritionists in discussing not only glucose data patterns but also the psychosocial impact of hypoglycemia.
In their article, Medication-Related Hypoglycemia: Causes and Treatments, Isaacs and Zolna present an overview of glucagon products available for hypoglycemia treatment, including instructions for use. They also highlight additional medications that influence blood glucose levels.
Lois Maurer, RDN details how impaired awareness of hypoglycemia can develop and describes educational programs that aim to restore awareness of low glucose levels in the article Educational Programs to Restore Hypoglycemia Awareness.
In the article, Hypoglycemic Confidence in People with Diabetes and their Loved Ones: The Dietitian's Role in Accentuating the Positive, Beebe and Polonsky present a case study and overview of how to use the Hypoglycemia Confidence scale to initiate discussion with individuals and their loved ones.
Burani details risk factors and suggests adjusted glucose targets and presents the broader scope of challenges older adults face as they manage diabetes care along with other comorbidities in The Uniqueness of Hypoglycemia in Elderly Individuals with Diabetes.
Post-bariatric hypoglycemia (PBH) is a potentially disabling complication of bariatric surgery that may not emerge until years after the procedure. In the article, Post-Bariatric Hypoglycemia: The Essential Role of the Registered Dietitian Nutritionist, Sheehan and the Joslin Diabetes Center Hypo Clinic team review etiology and treatment of PBH and highlight the essential role of RDNs.
The Hypoglycemia Prevention Initiative is conducting a study to identify approaches to assess hypoglycemia risk and incidence in the clinical setting. The study will also explore educational approaches to prevention. Warshaw interviews two researchers to share more about this study, and the targeted outcomes in The Endocrine Society's Efforts to Reduce the Burden of Hypoglycemia: An Interview with Drs. Lash and Boord Conducted by Hope Warshaw MMSc, RD, CDCES, BC-ADM.
Publish 2020-2021
PDF
From seasonal specials celebrating commemorative events and awareness campaigns to sales on soon-to-expire CPE activities and book titles for which new editions are just around the corner, don't miss this opportunity to grab cutting-edge resources at discounted prices.